About Contact Us Careers

Neoplasm Treatment Market Size and Forecast, by Type (Malignant, Benign), End-user (Specialty Clinics, Hospital, Cancer Research Center) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 3898
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Neoplasm Treatment Market Outlook:

Neoplasm Treatment Market size was over USD 241.74 billion in 2025 and is poised to exceed USD 638.51 billion by 2035, growing at over 10.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of neoplasm treatment is evaluated at USD 263.93 billion.

Global-Neoplasm-Treatment-Market-scope
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The growth of the market can be attributed to the increasing number of peoples suffering from malignant tumors, followed by the rising number of cases across the globe.  According to the data by the World Health Organization (WHO), over 10 million people died due to cancer in 2020, up from 9.6 million in 2018. Moreover, there were 2.26 million new cases of breast cancer, 2.21 million cases of lung cancer, and 1.41 million cases of prostate cancer in 2020 itself.

Neoplasms can be cancerous or non-cancerous growths in different organs of the body. Neoplasm is not swelling as in case of tumors, and a new unwanted growth. The factors causing the non-cancerous neoplasm are often unknown, as it doesn’t spread to other parts of the body. On the other hand, there are few factors that are linked to the growth of the cancerous neoplasm such as rise in the exposure to skin or toxin chemical. For instance, as per the American Academy of Dermatology Association estimated, nearly one in five Americans develops skin cancer in their lifetime.

Key Neoplasm Treatment Market Insights Summary:

  • Regional Highlights:

    • The North America neoplasm treatment market is expected to capture the largest revenue share by 2035, supported by the escalating incidence of cancer and the strong presence of advanced research institutes coupled with high healthcare spending in the region.
    • Europe is projected to witness notable growth through 2035, propelled by increased focus on neoplasm management, rising malignant cancer prevalence, and growing clinical trial activity across the region.

  • Segment Insights:

    • The malignant segment in the neoplasm treatment market is forecast to secure the dominant share over 2026–2035, driven by the accelerating global prevalence of cancerous neoplasms and increasing exposure to carcinogens linked to modern lifestyle habits.
    • The hospitals segment is projected to hold the largest share by 2035, underpinned by the expanding number of hospitals worldwide and sustained government investment in enhancing advanced treatment capabilities for diverse patient needs.

  • Key Growth Trends:

    • Increasing Exposure to Smoke
    • Increasing Geriatric Population

  • Major Challenges:

    • High Cost for the Treatment of Neoplasm
    • Lack of awareness among people in low and middle income countries for these treatment

  • Key Players: Thermo Fisher Scientific Inc., Bayer AG, Merck & Co., Inc., Novartis AG, Abbott Laboratories, Exelixis, Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Amgen Inc.

Global Neoplasm Treatment Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 241.74 billion
    • 2026 Market Size: USD 263.93 billion
    • Projected Market Size: USD 638.51 billion by 2035
    • Growth Forecasts: 10.2%

  • Key Regional Dynamics:

    • Largest Region: North America (Majority Share by 2035)
    • Fastest Growing Region: Europe
    • Dominating Countries: China, United States, India, Japan, Germany
    • Emerging Countries: Indonesia, Vietnam, Brazil, Mexico, United Arab Emirates

    • Last updated on : 20 November, 2025

Growth Drivers

  • Increasing Exposure to Smoke - Any area of the body can be affected as a result of cigarette smoking. Excessive smoking is injurious to health, and can make the condition worsen with time. Therefore, it is projected to surge the growth of the global neoplasm treatment market. According to the American Cancer Society, nearly 20 percent of cancers, and 30 percent of all cancer deaths are owing to the smoking in the United States.

  • Increasing Geriatric Population - The incidence rates of neoplasms increase with the rise in the elderly population’s percentage. With the increasing age, the        cells in the body get damaged, and are expected to drive the market’s growth. As per the reported data, in the year 2050,  more than 70 percent 80% of the world's old people is anticipated to live in low- and middle-income countries.

  • Increasing Exposure to Smoke - Any area of the body can be affected as a result of cigarette smoking. Excessive smoking is injurious to health, and can make the condition worsen with time. Therefore, it is projected to surge the growth of the global neoplasm treatment market. According to the American Cancer Society, nearly 20 percent of cancers, and 30 percent of all cancer deaths are owing to the smoking in the United States.

  • Increasing Geriatric Population - The incidences rates of neoplasm increase as the rise in the elderly population percentage. With the increasing age, the        cells in the body gets damaged, and are expected to drive the market’s growth. As per the reported data, in the year 2050, more than 70 percent of the world's old people is anticipated to live in low- and middle-income countries.

Challenges

  • High Cost for the Treatment of Neoplasm - There are treatment options that are critical and needed to be adopted in critical conditions such as surgery. Moreover, the cost charged by the doctors are high for the complex procedures. Therefore, it is expected to hamper the market’s growth in the upcoming years.
  • Lack of awareness among people in low and middle-income countries for these treatment
  • Lack of medical reimbursement policies for treatment of Neoplasm

Neoplasm Treatment Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

10.2%

Base Year Market Size (2025)

USD 241.74 billion

Forecast Year Market Size (2035)

USD 638.51 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Neoplasm Treatment Market Segmentation:

Type (Malignant, Benign)

The global neoplasm treatment market is segmented and analyzed for demand and supply by type into benign, and malignant, out of which, the malignant segment is anticipated to hold the notable share in the global neoplasm treatment market over the forecast period on account of the growing prevalence of malignant, i.e., cancerous neoplasm across the globe. In addition, malignant is a severe kind of neoplasm that usually grow faster than benign and can spread to the whole body of the patient, they are not controlled at the right time, and can invade the nearby tissues. Moreover, the higher exposure to carcinogens, backed by poor lifestyle habits in present times, is estimated to fuel the segment.  According to the World Health Organization, cancer accounted for nearly one in six deaths across the globe in the year 2020.

End-user (Specialty Clinics, Hospital, Cancer Research Center) 

The global neoplasm treatment market is also segmented and analyzed for demand and supply by end-user into specialty clinics, hospital, cancer research center, and others. Out of these, the hospitals segment is projected to hold the largest share over the forecast period in the global neoplasm treatment market. The growth of the segment can be owing to the increasing number of hospitals around the world for the treatment of diseases. Furthermore, the government invests in hospitals for providing treatment facilities to patients belonging to the lower income category. In addition, they are able to deal with the emergency cases with the advanced technologies, and it is expected to increase the segment’s growth in the market.  As per the data reported in 2020, the total number of hospitals in Japan accounted to more than 8,000. In addition, the number of hospitals in Korea has increased to more than 4,000 in the year 2020.

Our in-depth analysis of the global market includes the following segments:

         By Type
  • Malignant
  • Benign

        By End-User
  • Specialty Clinics
  • Hospital
  • Cancer Research Center
  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Neoplasm Treatment Market - Regional Analysis

North American Market Forecast   

North America industry is anticipated to account for largest revenue share by 2035, attributed to rising cases of cancer in the region.. The growth of the market can be attributed majorly to the rising cases of cancer in the region. According to the US National Cancer Institute, an estimated of 1,806,590 new cases of cancer were diagnosed in the United States in 2020. Moreover, the presence of major research institutes in the region, combined with high healthcare expenditure, is estimated to boost the market growth. In addition, there has been a higher awareness related to the advanced technologies for cancer diagnostics and treatment in terms of chemotherapy, radiation, and others that is further anticipated to boost the market’s growth in the region.

Europe Market Forecast

The European neoplasm treatment market, amongst the market in all the other regions, is also projected to have significant growth during the forecast period. The growth of the market can be attributed majorly to the surging emphasis on neoplasm treatment, followed by rising prevalence of malignant cancers in the countries such as the United Kingdom. Furthermore, the rising clinical trials, and development of drugs for the treatment is further predicted to boost the growth of the market in the region. In addition, the increasing approval of the drug and its treatment by the FDA is expected to contribute to the factors that are supporting the market’s growth in the region.

APAC Market Statistics

The Asia Pacific neoplasm treatment market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growing geriatric population, and increasing population percentage are the major factors that are anticipated to boost the growth of the neoplasm treatment market in the region over the forecast period. Furthermore, improving healthcare facilities and policies are further predicted to increase the market’s growth in the Asia Pacific region.

Global-Neoplasm-Treatment-Market-regional
Get Strategic Analysis by Region Now: Request Free Sample PDF

Neoplasm Treatment Market Players:

    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bayer AG
    • Merck & Co., Inc.
    • Novartis AG
    • Abbott Laboratories
    • Exelixis, Inc.
    • Boehringer Ingelheim GmbH
    • Teva Pharmaceutical Industries Ltd.
    • F. Hoffmann-La Roche
    • Amgen Inc.

Recent Developments

  • Exelixis Inc. announced the successful results for Cabozantinib in combination with immunotherapies in patients with advanced colorectal cancer.

  • Merck & Co announced the complete acquisition of Acceleron Pharma Inc., to explore the opportunities in medical research.

  • Report ID: 3898
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of neoplasm treatment is evaluated at USD 263.93 billion.

The global neoplasm treatment market size was worth over USD 241.74 billion in 2025 and is poised to grow at a CAGR of around 10.2%, reaching USD 638.51 billion revenue by 2035.

The North America neoplasm treatment market is expected to capture the largest revenue share by 2035, supported by the escalating incidence of cancer and the strong presence of advanced research institutes coupled with high healthcare spending in the region.

Key players in the market include Thermo Fisher Scientific Inc., Bayer AG, Merck & Co., Inc., Novartis AG, Abbott Laboratories, Exelixis, Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Amgen Inc.

Neoplasm Treatment Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos